NCT06094725 A Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Relacorilant Status COMPLETED Phase PHASE1
NCT05726292 A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer Status RECRUITING Phase PHASE2
NCT05347979 Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants Status COMPLETED Phase PHASE1
NCT04795479 T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04373265 Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol) Status COMPLETED Phase PHASE1
NCT04308590 A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas Status COMPLETED Phase PHASE3
NCT03776812 Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT03697109 A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome Status COMPLETED Phase PHASE3
NCT03674814 Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer Status COMPLETED Phase PHASE1
NCT03604198 Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03457597 Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s Status COMPLETED Phase PHASE1